A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the GlaxoSmithKline (GSK) Biologicals' Respiratory Syncytial Virus (RSV) Investigational Vaccine (GSK3003891A) in Healthy Pregnant Women and Infants Born to Vaccinated Mothers
Clinical trial NCT03191383 · WITHDRAWN
Trial details
- NCT number
- NCT03191383
- Sponsor
- GlaxoSmithKline
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-11
- Primary completion
- 2017-07-14
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.